C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2004
11/18/2004	CA2521580A1 Chemical compounds
11/17/2004	EP1477487A1 Improvement in the production of imidazole derivatives and novel intermediates of the derivatives
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1476787A1 Visible radiation sensitive composition
11/17/2004	EP1476444A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
11/17/2004	EP1476443A2 Process for preparing indolinone derivatives
11/17/2004	EP1476442A2 Lansoprazole polymorphs and processes for preparation thereof
11/17/2004	EP1476441A1 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides
11/17/2004	EP1476437A1 Novel tetrazole derivative useful as herbicides
11/17/2004	EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004	EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004	EP1476428A1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476164A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
11/17/2004	EP1476161A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1401442B1 S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	EP1075471B1 Indolyl derivatives as serotonergic agents
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP0973766B1 Quinoxalinediones
11/17/2004	EP0888338B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) 1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547578A Aminopyrrole compounds as antiinflammatory agents
11/17/2004	CN1547472A Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
11/17/2004	CN1547470A Use of phenyl pyridinyl methylaminomethyl piperidinyl methanone derivatives in the treatment of opioid dependence
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/16/2004	US6818773 Synthesis of 4-[(Z)-4-bromophenyl)(ethoxyimino) methyl]-1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbony)]-4'-methyl-1,4-′bipiperidine
11/16/2004	US6818769 Separately dissolve stoichiometric amount of pyridyl compound and equivalent of heterocyclic diamine in organic solvent, charge small amounts of solvent and diamine, and alkali carbonate to reactor, co-feed solutions while heating to react
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818715 Ligand system for novel complexes containing late transition metals which can be used for polymerization of unsaturated compounds and give branched polymers
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818655 2-aminoquinolines; cardiovascular, gastrointestinal, pyschological, respiratory and nervous system disorders
11/16/2004	US6818648 Psychological disorders; anxiolytic agents; antidepressants; eating disorders; alcoholism; drug abuse; antiinflammatory agents
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818631 4-fluoroalkyl substituent; agriculture, horticulture; plant disease control
11/16/2004	US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
11/16/2004	CA2145181C Process for preparing 1-2,-substituted-5-formylimidazoles
11/16/2004	CA2116003C Arylalkanoic acid resolution
11/16/2004	CA2107008C Antiarrhythmic and cardioprotective substituted -1(2h)isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096798A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096794A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
11/11/2004	WO2004096793A1 New alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants
11/11/2004	WO2004096792A2 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors
11/11/2004	WO2004096781A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
11/11/2004	WO2004096780A1 Quinoxalinone-3- one derivatives as orexin receptor antagonists
11/11/2004	WO2004096779A1 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect
11/11/2004	WO2004096777A1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
11/11/2004	WO2004096774A1 Acyl isoindoline derivatives and acyl isoquinoline derivatives as anti-viral agents
11/11/2004	WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004	WO2004096768A1 Anti-diabetic agents
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004096213A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	WO2004096210A1 Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
11/11/2004	WO2004096135A2 Inhibitors of akt activity
11/11/2004	WO2004096131A2 Inhibitors of akt activity
11/11/2004	WO2004096129A2 Inhibitors of akt activity
11/11/2004	WO2004096128A2 Hiv integrase inhibitors
11/11/2004	WO2004087053A9 Dipeptidyl peptidase inhibitors
11/11/2004	WO2004078748A3 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
11/11/2004	WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004	WO2004043337A3 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2004018418A3 Hydrophilic chemiluminescent acridinium labeling reagents
11/11/2004	WO2004017917A3 Method for the prevention and/or treatment of atherosclerosis
11/11/2004	WO2003079973A3 Mitotic kinesin inhibitors
11/11/2004	WO2003059258A3 Compositions and methods for treating heart failure
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224993 Diphenylurea compounds
11/11/2004	US20040224987 Crystalline form C of omeprazole sodium and the related process of its preparation, a crystalline form D of omeprazole sodium and the related process of its preparation, and a process for preparation of crystalline form a of omeprazole sodium
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224975 Nicotinamide derivatives useful as PDE4 inhibitors
11/11/2004	US20040224968 Drugs for treatment of tumors, antidiabetic agents, antiproliferation agents and injections
11/11/2004	US20040224967 Drugs for treatment for diseases such as cancer using tyrosine kinases and enzyme inhibitors
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224956 Crystal of 6-[4-(4-pyridylamino)phenyl]-4,5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004	US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224946 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors

1 ... 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 ... 1080